Yiming Gu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yiming Gu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chen Xu
Department of Vascular Surgery and Intervention, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China
1 shared publication - Guoxiong Xu
Department of Intervention Radiology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou, China
1 shared publication - Hai-Bin Shi
Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1 shared publication - Haibin Shi
Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
1 shared publication - Linbo Zhao
Department of Interventional Radiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China
1 shared publication - Sheng Liu
Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- 21 January 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 225, 107605
Predictive value of computed tomography perfusion for acute ischemic stroke patients with ASPECTS < 6 in an early time window
- 21 January 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 225, 107605
Predictive value of computed tomography perfusion for acute ischemic stroke patients with ASPECTS < 6 in an early time window
- Open Access
- 7 November 2022
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-9
Prognostic nomogram for acute pancreatitis after percutaneous biliary stent insertion in patients with malignant obstruction
This study aimed to develop and validate a nomogram to predict the risk of pancreatitis after percutaneous transhepatic biliary stent insertion (PTBS) in patients with malignant biliary obstruction (MBO). We enrolled 314 patients who underwent PTBS for MBO from March 2016 to July 2021 in this retrospective study. We used univariate analysis to identify potential risk factors, while a multivariate logistic regression model was employed to establish a nomogram for predicting the risk of pancreatitis. The discrimination and calibration of the nomogram were evaluated by estimating the area under the receiver operator characteristic curve (AUC) and by bootstrap resampling and visual inspection of the calibration curve. The clinical utility of the nomogram was assessed using decision curve analysis (DCA). After the procedure, 41 (13.1%) patients developed pancreatitis. Based on multivariate logistic regression analysis, young age (OR = 2.57, 95% CI 1.16 to 5.69), stent insertion across the papilla (OR = 6.47, 95% CI 2.66 to 15.70), and visualization of the pancreatic duct (OR = 15.40, 95% CI 6.07 to 39.03) were associated with an elevated risk of pancreatitis. Importantly, the performance of the nomogram was satisfactory, with an identical AUC (0.807, 95% CI 0.730 to 0.883) and high-level agreement between predicted and observed probabilities as suggested in calibration curves. The DCA curve subsequently confirmed the clinical utility. A predictive nomogram for pancreatitis after PTBS in patients with MBO was successfully established in the present study.
- 7 November 2022
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-9
Open AccessPrognostic nomogram for acute pancreatitis after percutaneous biliary stent insertion in patients with malignant obstruction
This study aimed to develop and validate a nomogram to predict the risk of pancreatitis after percutaneous transhepatic biliary stent insertion (PTBS) in patients with malignant biliary obstruction (MBO). We enrolled 314 patients who underwent PTBS for MBO from March 2016 to July 2021 in this retrospective study. We used univariate analysis to identify potential risk factors, while a multivariate logistic regression model was employed to establish a nomogram for predicting the risk of pancreatitis. The discrimination and calibration of the nomogram were evaluated by estimating the area under the receiver operator characteristic curve (AUC) and by bootstrap resampling and visual inspection of the calibration curve. The clinical utility of the nomogram was assessed using decision curve analysis (DCA). After the procedure, 41 (13.1%) patients developed pancreatitis. Based on multivariate logistic regression analysis, young age (OR = 2.57, 95% CI 1.16 to 5.69), stent insertion across the papilla (OR = 6.47, 95% CI 2.66 to 15.70), and visualization of the pancreatic duct (OR = 15.40, 95% CI 6.07 to 39.03) were associated with an elevated risk of pancreatitis. Importantly, the performance of the nomogram was satisfactory, with an identical AUC (0.807, 95% CI 0.730 to 0.883) and high-level agreement between predicted and observed probabilities as suggested in calibration curves. The DCA curve subsequently confirmed the clinical utility. A predictive nomogram for pancreatitis after PTBS in patients with MBO was successfully established in the present study.